viaskin peanut - search results

If you're not happy with the results, please do another search
Peanuts

Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for Peanut Allergy

An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.
Jigsaw Puzzle

Milk and Peanut Clinical Trial Advances

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.
DBV Patch Closeup

DBV Completes Phase III Study of Peanut Patch

The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.
Viaskin Peanut

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of 2017

The study received higher-than-expected patient demand.
Packaged Foods

Study: Peanut Immunotherapy Significantly Reduces Risks Due to Cross-Contact in Common Packaged Foods

The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Peanut Patch Receives FDA's Breakthrough Therapy Designation

The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.
SnackSafely.com Newsletter Archive

SnackSafely.com Newsletter: 2019/08/08

DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut for the Treatment of Peanut Allergy (+4 Articles)
Paliforzia (AR101)

FAQ for Palforzia, the First FDA Approved Therapy for Food Allergy

What it is, what it treats, who it is for, how it is used, et al.
OIT

Leading Allergists, Researchers and Food Allergy Advocates to Discuss State of ‘Food Oral Immunotherapy...

The summit intends to address the risks and benefits of OIT, OIT implementation in practice and the gaps in knowledge about OIT to enable physicians to have a better understanding of this therapy and to help patients make fully-informed choices about treatment options.